Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL78483 | 0.72 | — | — | |
| SCHEMBL2339042 | 0.71 | — | — | |
| SCHEMBL13192911 | 0.71 | — | — | |
| SCHEMBL84210 | 0.69 | ALDH1A1 (0.33) | ALDH1A1 | |
| SCHEMBL11575460 | 0.67 | — | — | |
| SCHEMBL4627087 | 0.67 | — | — | |
| SCHEMBL7158083 | 0.67 | — | — | |
| SCHEMBL11804104 | 0.67 | — | — | |
| SCHEMBL6903741 | 0.67 | — | — | |
| SCHEMBL11129029 | 0.67 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 127 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3075750-B1 | METHOD FOR PREPARING VINYL CHLORIDE-BASED RESIN | HANWHA CHEMICAL CORP (KR) | 2020-01-08 | — | — | EP | claimed |
| US-9637580-B2 | Method for preparing vinyl chloride-based resin | HANWHA CHEMICAL CORPORATION (KR) | 2017-05-02 | — | — | US | claimed |
| US-20160376387-A1 | METHOD FOR PREPARING VINYL CHLORIDE-BASED RESIN | HANWHA CHEMICAL CORPORATION (KR) | 2016-12-29 | — | — | US | claimed |
| EP-3075750-A1 | METHOD FOR PREPARING VINYL CHLORIDE-BASED RESIN | Hanwha Chemical Corporation (KR) | 2016-10-05 | — | — | EP | claimed |
| US-20260144848-A1 | METHOD FOR PREDICTING RESPONSE TO A CANCER TREATMENT | PEPTOMYC, S.L. (ES) | 2026-05-28 | — | — | US | disclosed |
| EP-4724083-A1 | COMBINATION THERAPY WITH BRAF INHIBITORS FOR THE TREATMENT OF CANCER | Fundació Privada Institut d'Investigació Oncològica de Vall Hebron (ES) | 2026-04-15 | — | — | EP | disclosed |
| EP-4724082-A1 | OMOMYC AND KRAS INHIBITORS COMBINATION THERAPY FOR THE TREATMENT OF CANCER | Peptomyc, S.L. (ES) | 2026-04-15 | — | — | EP | disclosed |
| EP-4724100-A1 | COMBINATION THERAPY WITH MEK INHIBITORS FOR THE TREATMENT OF CANCER | Fundació Privada Institut d'Investigació Oncològica de Vall Hebron (ES) | 2026-04-15 | — | — | EP | disclosed |
| EP-4720172-A1 | SIDE-CHAIN FUNCTIONALIZED POLYNORBORNENES AS IONOMERS AND AS MEMBRANE MATERIALS FOR ALKALINE ELECTROLYSIS OF WATER, AND FUEL CELL | Forschungszentrum Jülich GmbH (DE) | 2026-04-08 | — | — | EP | disclosed |
| EP-4695608-A1 | METHOD FOR ASSESSING OR MONITORING THE RESPONSE TO A CANCER TREATMENT | Peptomyc, S.L. (ES) | 2026-02-18 | — | — | EP | disclosed |
| WO-2025262249-A1 | PREVENTION OF COGNITIVE-DECLINE DISORDERS DERIVED FROM RADIOTHERAPY | UNIVERSIDAD DE NAVARRA (ES) | 2025-12-26 | — | — | WO | disclosed |
| WO-2025242796-A1 | HYDROGENATED SIDE-CHAIN FUNCTIONALIZED POLYNORBORNENE-ANION EXCHANGE POLYMERS AS MEMBRANE MATERIALS FOR ALKALINE WATER ELECTROLYSIS AND FUEL CELLS | Forschungszentrum Jülich GmbH (DE) | 2025-11-27 | — | — | WO | disclosed |
| US-4314043-A | POLYSILOXANE-ADDITION COPOLYMERS | ASAHI GLASS COMPANY, LTD. (JP) | 1982-02-02 | — | — | US | disclosed |
| WO-1980002839-A1 | CURABLE ORGANIC RESIN COMPOSITIONS AND FOAMING METHOD | GEN ELECTRIC | 1980-12-24 | — | — | WO | disclosed |
| US-4239725-A | CATIONICALLY POLYMERIZABLE IN THE PRESENCE OF A CATALYST OF A DIARYL IODONIUM SALT, A COPPER SALT AND A REDUCING AGENT | GENERAL ELECTRIC COMPANY (US) | 1980-12-16 | — | — | US | disclosed |
| US-4237258-A | CONTAINING MINOR AMOUNTS OF ETHYLENICALLY UNSATURATED MONOMERS; MOLDING MATERIAL | MONTEDISON S.P.A. (IT) | 1980-12-02 | — | — | US | disclosed |
| US-4225691-A | DIARYLDIIODONIUM SALTS | GENERAL ELECTRIC COMPANY (US) | 1980-09-30 | — | — | US | disclosed |
| US-4192924-A | DIARYLIOPONIUM SALT REDOX CATALYST | GENERAL ELECTRIC COMPANY (US) | 1980-03-11 | — | — | US | disclosed |
| US-4083725-A | CINNAMIC ACID PHOTOSENSITIVE RESIN AND A HALOGEN SUBSTITUTED BENZANTHRONE SENSITIZER | MITSUBISHI CHEMICAL INDUSTRIES LTD. (JA) | 1978-04-11 | — | — | US | disclosed |
| US-4063953-A | POLYETHERS, POLYEPICHLOROHYDRIN, VINYL CINNAMATES | MITSUBISHI CHEMICAL INDUSTRIES, LTD. (JA) | 1977-12-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260144848-A1 | METHOD FOR PREDICTING RESPONSE TO A CANCER TREATMENT | SELE, SELL, SELPLG | ALDH1A1 1786/4885TSHR 3031/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.